Total Payments
$16,268
2024 Payments
$1,650
Companies
49
Transactions
1,111
Medicare Patients
46,305
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$16,060 (98.7%)
Education$207.46 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,060 | 1,101 | 98.7% |
| Education | $207.46 | 10 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $2,776 | 203 | $0 (2024) |
| Amgen Inc. | $1,520 | 123 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,477 | 95 | $0 (2024) |
| Novo Nordisk Inc | $1,314 | 93 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,049 | 69 | $0 (2024) |
| GlaxoSmithKline, LLC. | $838.27 | 65 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $696.52 | 56 | $0 (2024) |
| Amarin Pharma Inc. | $656.35 | 51 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $650.01 | 32 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $495.26 | 28 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,650 | 95 | Lilly USA, LLC ($406.80) |
| 2023 | $2,556 | 164 | Lilly USA, LLC ($603.09) |
| 2022 | $2,534 | 152 | Lilly USA, LLC ($390.90) |
| 2021 | $2,176 | 147 | Lilly USA, LLC ($272.21) |
| 2020 | $1,785 | 114 | Amgen Inc. ($341.07) |
| 2019 | $1,577 | 122 | Lilly USA, LLC ($248.29) |
| 2018 | $1,918 | 154 | Lilly USA, LLC ($277.84) |
| 2017 | $2,072 | 163 | Lilly USA, LLC ($327.42) |
All Payment Transactions
1,111 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.26 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.36 | General |
| Category: Cardiovascular | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Biological | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $34.36 | General |
| Category: Neurology | ||||||
| 10/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $3.61 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Endocrinology | ||||||
| 10/08/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: DERMATOLOGY | ||||||
| 10/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $6.74 | General |
| Category: Gastroenterology | ||||||
| 09/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: Cardio-renal | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 50 | 12,124 | 16,886 | $1.4M | $446,782 |
| 2022 | 44 | 11,032 | 14,937 | $1.2M | $378,338 |
| 2021 | 51 | 11,876 | 16,143 | $1.3M | $428,341 |
| 2020 | 49 | 11,273 | 15,224 | $1.2M | $379,454 |
Total Patients
46,305
Total Services
63,190
Medicare Billing
$1.6M
Procedure Codes
194
All Medicare Procedures & Services
194 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 708 | 1,040 | $179,230 | $86,987 | 48.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 684 | 684 | $233,244 | $84,529 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 383 | 536 | $60,042 | $29,648 | 49.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 16 | 1,620 | $76,950 | $29,464 | 38.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 111 | 456 | $52,440 | $27,499 | 52.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 658 | 667 | $82,708 | $19,310 | 23.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 66 | 343 | $49,049 | $15,084 | 30.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 670 | 728 | $51,688 | $11,977 | 23.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 75 | 88 | $52,800 | $11,687 | 22.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 699 | 833 | $77,469 | $10,886 | 14.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 730 | 975 | $43,875 | $10,077 | 23.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 660 | 668 | $42,084 | $9,837 | 23.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 738 | 1,088 | $19,584 | $9,131 | 46.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 725 | 982 | $31,424 | $7,451 | 23.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 551 | 585 | $59,670 | $7,311 | 12.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 97 | 99 | $6,930 | $6,791 | 98.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 667 | 708 | $26,904 | $6,254 | 23.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 147 | 155 | $28,365 | $5,976 | 21.1% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 280 | 280 | $22,680 | $5,280 | 23.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 48 | 53 | $10,600 | $4,640 | 43.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 63 | 74 | $10,878 | $4,511 | 41.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 23 | 24 | $11,808 | $3,651 | 30.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 268 | 383 | $15,320 | $3,631 | 23.7% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 661 | 674 | $14,154 | $3,419 | 24.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 63 | 116 | $17,748 | $3,144 | 17.7% |
About Dr. Richard Henderson, M.D
Dr. Richard Henderson, M.D is a Internal Medicine healthcare provider based in Lubbock, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427002336.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Henderson, M.D has received a total of $16,268 in payments from pharmaceutical and medical device companies, with $1,650 received in 2024. These payments were reported across 1,111 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($16,060).
As a Medicare-enrolled provider, Henderson has provided services to 46,305 Medicare beneficiaries, totaling 63,190 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 194 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Lubbock, TX
- Active Since 05/22/2006
- Last Updated 10/27/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1427002336
Products in Payments
- ENTRESTO (Drug) $1,015
- TRULICITY (Drug) $1,009
- JARDIANCE (Drug) $918.30
- MOUNJARO (Drug) $749.68
- FARXIGA (Drug) $739.79
- XIFAXAN (Drug) $696.52
- Vascepa (Drug) $656.35
- Kerendia (Drug) $650.01
- Ozempic (Drug) $594.22
- ELIQUIS (Drug) $513.47
- TRELEGY ELLIPTA (Drug) $485.23
- LEQVIO (Drug) $454.87
- Otezla (Drug) $405.36
- XARELTO (Drug) $397.89
- EVENITY (Biological) $352.52
- Prolia (Biological) $329.81
- Aimovig (Biological) $328.43
- Tymlos (Biological) $297.97
- Victoza (Drug) $294.91
- Rybelsus (Drug) $191.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lubbock
Dr. Mohammad Ansari, M.d, M.D
Internal Medicine — Payments: $257,147
Internal Medicine $257,147
Mohammed Bakdash, M.d, M.D
Internal Medicine — Payments: $241,102
Internal Medicine $241,102
Sharma Prabhakar, M.d, M.D
Internal Medicine — Payments: $47,803
Internal Medicine $47,803
Dr. Joseph Wolcott, M.d, M.D
Internal Medicine — Payments: $37,371
Internal Medicine $37,371
Jose Suarez, Md, MD
Internal Medicine — Payments: $36,074
Internal Medicine $36,074
Dr. Michael Mcpherson, Md, MD
Internal Medicine — Payments: $30,601
Internal Medicine $30,601